Tardive dyskinesia in patients with depressive disrder treated with flupentixlmelitracin - results from a 12-month, prospective, open study under naturalistic conditions in Bangladesh

被引：0
|
作者：
Haque, Rashimul
Kabir, Kaniza
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
158
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [1] Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions
    Szafranski, Tomasz
    [J]. PSYCHIATRIA POLSKA, 2014, 48 (06) : 1155 - 1165
  • [2] Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study
    Ascher-Svanum, Haya
    Zhu, Baojin
    Faries, Douglas
    Peng, Xiaomei
    Kinon, Bruce J.
    Tohen, Mauricio
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (10) : 1580 - 1588
  • [3] Smoking reduction in psychiatric inpatients is feasible: results from a 12-month prospective study
    Michopoulos, Ioannis
    Rizos, Emmanouil
    Gournellis, Rossetos
    Karvouni, Andromachi
    Kotsioumpa, Ioanna
    Douzenis, Athanasios
    [J]. ANNALS OF GENERAL PSYCHIATRY, 2015, 14
  • [4] Smoking reduction in psychiatric inpatients is feasible: results from a 12-month prospective study
    Ioannis Michopoulos
    Emmanouil Rizos
    Rossetos Gournellis
    Andromachi Karvouni
    Ioanna Kotsioumpa
    Athanasios Douzenis
    [J]. Annals of General Psychiatry, 14
  • [5] The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study
    Ahn, Yong Min
    Lee, Kyu Young
    Kim, Chul-Eung
    Kang, Dae-Yeob
    Seok, Jeong-Ho
    Shin, Young Min
    Chung, In-Won
    Jun, Tae-Youn
    Chang, Jae Seung
    Kim, Yong Sik
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (08) : 568 - 577
  • [6] Results from a 12-month open-label safety study of lumateperone (ITI-007) in patients with stable symptoms of schizophrenia
    Correll, C. U.
    Vanover, K. E.
    Durgam, S.
    Weingart, M.
    Davis, R.
    Satlin, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S455 - S456
  • [7] Ten kHz spinal cord stimulation for the treatment of chronic peripheral polyneuropathy: 12-Month results from prospective open-label pilot study
    Galan, Vincent
    Scowcroft, James
    Chang, Paul
    Li, Sean
    Staats, Peter
    Subbaroyan, Jeyakumar
    Caraway, David
    [J]. PAIN PRACTICE, 2021, 21 (08) : 898 - 906
  • [8] Additional Results From a 12-Month Open-Label Safety Study of Lumateperone (ITI-007) in Patients With Stable Symptoms of Schizophrenia
    Satlin, Andrew
    Vanover, Kimberly
    Durgam, Suresh
    Mates, Sharon
    Davis, Robert
    Correll, Christoph
    [J]. NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 493 - 494
  • [9] Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study
    Ticha, Veronika
    Kodym, Roman
    Pocikova, Zuzana
    Kadlecova, Pavla
    [J]. CLINICAL DRUG INVESTIGATION, 2017, 37 (02) : 175 - 186
  • [10] Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study
    Veronika Tichá
    Roman Kodým
    Zuzana Počíková
    Pavla Kadlecová
    [J]. Clinical Drug Investigation, 2017, 37 : 175 - 186
12345